scholarly journals Enhancement of β-Glucan Biological Activity Using a Modified Acid-Base Extraction Method from Saccharomyces cerevisiae

Molecules ◽  
2021 ◽  
Vol 26 (8) ◽  
pp. 2113
Author(s):  
Enas Mahmoud Amer ◽  
Saber H. Saber ◽  
Ahmad Abo Markeb ◽  
Amal A. Elkhawaga ◽  
Islam M. A. Mekhemer ◽  
...  

Beta glucan (β-glucan) has promising bioactive properties. Consequently, the use of β-glucan as a food additive is favored with the dual-purpose potential of increasing the fiber content of food products and enhancing their health properties. Our aim was to evaluate the biological activity of β-glucan (antimicrobial, antitoxic, immunostimulatory, and anticancer) extracted from Saccharomyces cerevisiae using a modified acid-base extraction method. The results demonstrated that a modified acid-base extraction method gives a higher biological efficacy of β-glucan than in the water extraction method. Using 0.5 mg dry weight of acid-base extracted β-glucan (AB extracted) not only succeeded in removing 100% of aflatoxins, but also had a promising antimicrobial activity against multidrug-resistant bacteria, fungi, and yeast, with minimum inhibitory concentrations (MIC) of 0.39 and 0.19 mg/mL in the case of resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa, respectively. In addition, AB extract exhibited a positive immunomodulatory effect, mediated through the high induction of TNFα, IL-6, IFN-γ, and IL-2. Moreover, AB extract showed a greater anticancer effect against A549, MDA-MB-232, and HepG-2 cells compared to WI-38 cells, at high concentrations. By studying the cell death mechanism using flow-cytometry, AB extract was shown to induce apoptotic cell death at higher concentrations, as in the case of MDA-MB-231 and HePG-2 cells. In conclusion, the use of a modified AB for β-glucan from Saccharomyces cerevisiae exerted a promising antimicrobial, immunomodulatory efficacy, and anti-cancer potential. Future research should focus on evaluating β-glucan in various biological systems and elucidating the underlying mechanism of action.

2014 ◽  
Vol 1 (9) ◽  
pp. 303-314 ◽  
Author(s):  
Antonio Rego ◽  
◽  
Ana Duarte ◽  
Flavio Azevedo ◽  
Maria Sousa ◽  
...  

Author(s):  
Fernando J. Scariot ◽  
Luciane Jahn ◽  
Ana Paula L. Delamare ◽  
Sergio Echeverrigaray

APOPTOSIS ◽  
2016 ◽  
Vol 21 (7) ◽  
pp. 866-872 ◽  
Author(s):  
F. J. Scariot ◽  
L. M. Jahn ◽  
J. P. Maianti ◽  
A. P. L. Delamare ◽  
S. Echeverrigaray

2007 ◽  
Vol 85 (1) ◽  
pp. 49-55 ◽  
Author(s):  
Mustapha Aouida ◽  
Halima Mekid ◽  
Omrane Belhadj ◽  
Lluis M. Mir ◽  
Omar Tounekti

Bleomycin is a highly potent cytotoxic and genotoxic agent used in the chemotherapy of various types of tumors. It is a radiomimetic anticancer drug that produces single- and double-stranded DNA breaks in a catalytic way. Using Saccharomyces cerevisiae as a model system, we show that when a high amount of bleomycin molecules is internalized (100 µmol/L), morphological changes identical to those usually associated with apoptosis, i.e., a sub-G1 region peak, chromatin condensation, and very rapid DNA fragmentation into oligonucleosomal-sized fragments, are observed. The known bleomycin inhibitors cobalt and EDTA were able to prevent bleomycin nucleasic activity and thus apoptotic cell death. However, both oligomycin, a potent inhibitor of the mitochondial F0F1-ATPase, and antimycin, a drug affecting mitochondria respiration, were unable to prevent the bleomycin-induced apoptotic-like cell death. These results suggest that high bleomycin concentrations induce an apoptosis-like mitochondria-independent cell death in yeast.


Author(s):  
Fernando J. Scariot ◽  
Mariliza S. Pansera ◽  
Ana Paula L. Delamare ◽  
Sergio Echeverrigaray

Sign in / Sign up

Export Citation Format

Share Document